One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2020-137245
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 3 |
Affiliation: Barwon Health, Geelong Hospital, Institut Bergonié, Beatson West of Scotland Cancer Centre, Epizyme (United States), Hôpital Lyon Sud, Peter MacCallum Cancer Centre, Centre Hospitalier Universitaire de Lille, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, University of Michigan–Ann Arbor, Institut Gustave Roussy, Université de Caen Normandie, Imperial College Healthcare NHS Trust, Hammersmith Hospital, Monash University, Monash Health, McGill University, Jewish General Hospital, Memorial Sloan Kettering Cancer CenterAnalyzing Efficacy Outcomes from the Phase 2 Study of Single-Agent Tazemetostat As Third-Line Therapy in Patients with Relapsed or Refractory Follicular Lymphoma to Identify Predictors of Response
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
